Kronos Bio Inc (KRON) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Kronos Bio Inc

NASDAQ | KRON

0.80

USD

-0.036 (-4.31%)

AT CLOSE (AS OF Apr 3, 2025)

$51M

MARKET CAP

P/E Ratio

-1.43

EPS

$1.6

52 Week High

$0.69

52 Week Low

LIFE SCIENCES

Sector

KRON Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

KRON Technicals

Tags:

KRON Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	-$44M
Total Revenue	$9.8M
Cost Of Revenue	$54M
Costof Goods And Services Sold	-
Operating Income	-$93M
Selling General And Administrative	$25M
Research And Development	$49M
Operating Expenses	$103M
Investment Income Net	-
Net Interest Income	$6.8M
Interest Income	$6.8M
Interest Expense	-
Non Interest Income	$9.8M
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$1.7M
Income Before Tax	-$86M
Income Tax Expense	$0
Interest And Debt Expense	-
Net Income From Continuing Operations	-$86M
Comprehensive Income Net Of Tax	-$86M
Ebit	-$93M
Ebitda	-$62M
Net Income	-$86M

Revenue & Profitability

Earnings Performance

KRON Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2024)

Field	Value (USD)
Total Assets	$124M
Total Current Assets	$115M
Cash And Cash Equivalents At Carrying Value	$85M
Cash And Short Term Investments	$112M
Inventory	-
Current Net Receivables	-
Total Non Current Assets	$9.1M
Property Plant Equipment	$3.8M
Accumulated Depreciation Amortization Ppe	$8.6M
Intangible Assets	-
Intangible Assets Excluding Goodwill	-
Goodwill	-
Investments	-
Long Term Investments	$0
Short Term Investments	$28M
Other Current Assets	$2.8M
Other Non Current Assets	$112K
Total Liabilities	$37M
Total Current Liabilities	$15M
Current Accounts Payable	$2.4M
Deferred Revenue	$1.9M
Current Debt	-
Short Term Debt	$3.4M
Total Non Current Liabilities	$22M
Capital Lease Obligations	$25M
Long Term Debt	-
Current Long Term Debt	-
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$25M
Other Current Liabilities	$53K
Other Non Current Liabilities	-
Total Shareholder Equity	$88M
Treasury Stock	-
Retained Earnings	-$595M
Common Stock	$60K
Common Stock Shares Outstanding	$60M

yearly Cash Flow (As of Dec 31, 2024)

Field	Value (USD)
Operating Cashflow	-$65M
Payments For Operating Activities	$5.8M
Proceeds From Operating Activities	-
Change In Operating Liabilities	-$14M
Change In Operating Assets	-$3.3M
Depreciation Depletion And Amortization	$1.7M
Capital Expenditures	$4K
Change In Receivables	-
Change In Inventory	-
Profit Loss	-$86M
Cashflow From Investment	$85M
Cashflow From Financing	$245K
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	$245K
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$86M

yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	-$44M
Total Revenue	$9.8M
Cost Of Revenue	$54M
Costof Goods And Services Sold	-
Operating Income	-$93M
Selling General And Administrative	$25M
Research And Development	$49M
Operating Expenses	$103M
Investment Income Net	-
Net Interest Income	$6.8M
Interest Income	$6.8M
Interest Expense	-
Non Interest Income	$9.8M
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$1.7M
Income Before Tax	-$86M
Income Tax Expense	$0
Interest And Debt Expense	-
Net Income From Continuing Operations	-$86M
Comprehensive Income Net Of Tax	-$86M
Ebit	-$93M
Ebitda	-$62M
Net Income	-$86M

KRON Profile

Kronos Bio Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery and development of new cancer therapies. The company is headquartered in San Mateo, California.

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.02	9.42%	-	742,693,504
NVDA	$101.80	-7.81%	$2.68T	334,149,797
INTC	$22.43	2.05%	$95.85B	240,924,655
F	$9.55	-5.96%	$39.53B	213,326,329
LCID	$2.32	-3.33%	$7.67B	210,875,217

Symbol	Price	Change %	Market Cap	Volume
JNJ	$160.56	3.35%	$399.65B	9,908,361
PG	$172.57	1.81%	$399.61B	6,993,394
NVO	$67.12	-1.65%	$308.32B	8,797,694
AZN	$74.03	2.50%	$225.70B	6,150,517
MRK	$86.38	-0.25%	$220.07B	12,113,104

Symbol	Price	Change %	Market Cap	Volume
VCIG	$5.99	1,796.17%	$26.40M	310,904
MKTW	$9.19	1,684.81%	$19.91M	117,875
PTIX	$0.42	84.14%	$4.04M	177,332,811
MRM	$0.65	74.84%	$2.91M	51,693,935
OSRH	$2.47	68.03%	$40.06M	89,471,971

Symbol	Price	Change %	Market Cap	Volume
ALDX	$1.42	-73.33%	$326.91M	21,865,554
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
OMQS	$0.04	-66.36%	$1.50M	950,669

Quick Links

KRON $0.80 (-4.31%) Quote details